The role of C-reactive protein in infl ammatory processes of some diseases in pets
Article Sidebar
Published:
Apr 30, 2015
Keywords:
C-Reactive Protein infl ammation biomarker immune system
Main Article Content
Abstract
C-Reactive Protein (CRP) is an Acute phase protein (APP) that can be detected in blood. CRP is made by the liver to respond to infl ammation in the body. When infl ammation in the body occurs, several types of cytokines and substances act to stimulate many parts of the body to respond to infl ammation. CRP levels in the blood can be used to indicate the severity of the infl ammation that occurs in the body. It is also used to predict the incidence of certain diseases, especially cardiovascular disease and diabetes mellitus. CRP is commonly used to detect and observe the trend of concentration in the blood and evaluate the physical condition and progression of the disease.
Article Details
How to Cite
Ruamrungsri, N., & Nganvongpanit, K. (2015). The role of C-reactive protein in infl ammatory processes of some diseases in pets. Veterinary Integrative Sciences, 13(1), 3–12. Retrieved from https://he02.tci-thaijo.org/index.php/vis/article/view/146411
Section
Research Articles
Publishing an article with open access in Veterinary Integrative Sciences leaves the copyright with the author. The article is published under the Creative Commons Attribution License 4.0 (CC-BY 4.0), which allows users to read, copy, distribute and make derivative works from the material, as long as the author of the original work is cited.
References
Kjelgaard-Hansan M. (2004). Canine C-reactive protein : a study on the applicability of canine serum C-reactive protein. Ph.D. Thesis, The Royal Veterinary and Agricultural University. McClure V., can Schoor M., Thompson P. N., Kjelgaard-Hansan M. & Goddard A. (2013). Evaluation of the use of serum C- reactive protein concentration to predict outcome in puppies infected with canine parvovirus. Journal of the American Veterinary Medical Association, 243(3), 361-366.
Mold C. H. G. and Du Clos T. W. (1999). Regulation of complement activation by C-reactive protein. US National Library of Medicine National Institutes of Health, 42(1-3), 23-30.
Nakamura M., Takahashi M., Ohno K., Koshino A., Nakashima K., Setoguchi A., . . . Tsujimoto H. (2008). C-Reactive Protein Concentration in Dogs with Various Diseases. Journal of Veterinary Medical Science., 70(2), 127-131.
Osei-Bimphong A., Meek J. H. and Lewis S. M. (2007). ESR or CRP? A comparison of their clinical utility. Hematology, 12(4), 353-357.
Paffen E. and deMaat M. P. M. (2006). C-reactive protein in atherosclerosis : A causal factor? Cardiovascular Research, 71(1), 30-39.
Peisajovich A., Marnell L., Mold C. and Du Clos T. W. (2008). C-reactive protein at the interface between innate immunity and infl ammation. Expert Review Clinical Immunology, 4(3), 379-390.
Pradhan A. D., Manson J. E., Rifai N., Buring J. E. and Ridker, P. M. (2001). C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. Journal of the American Medical Association, 286(3), 327-334.
R. O. Leal, S. Gil, N. Sepúlveda, D. McGahie, A. Duarte, M. M. R. E. Niza, & Tavares, L. (2014). Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-v therapy. Journal of Small Animal Practice, 55, 39-45.
Roman Dabrowski, Marek Szczubial, Krzysztof Kostro, Wladyslaw Wawron, Jose J. Ceron, & Tvarijonaviciute, A. (2014). Serum insulin-like growth factor-1 and C-reactive protein concentrations before and after ovariohysterectomy in bitches with pyometra. Theriogenology 83(4), 474-7.
Rutemark, C., Alicot, E., Bergman, A., Ma, M., Getahun, A., Ellmerich, S., … Heyman, B. (2011). Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proceedings of the National Academy of Sciences of the United States of America, 108 (43), E934–942.
Shida T., Kuribayashi T., Seita T., Maruo T. and Yamamoto S. (2011). Characteristics of C-reactive protein(CRP), alpha-acid Glycoprotein(AAG) and Serum Amyloid A (SAA) in Dogs and Cats with Malignant cancer. International Journal of Applied Research in Veterinary Medicine, 9(4), 376-381.
Sjöwall, C., Wetterö, J., Bengtsson, T., Askendal, A., Almroth, G., Skogh, T., & Tengvall, P. (2007). Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fl uid-phase CRP–C1q interaction. Biochemical and Biophysical Research Communications, 352(1), 251–258.
Smith, R. P., & Lipworth, B. J. (1995). C-reactive protein in simple community-acquired pneumonia. Chest, 107(4), 1028–1031.
Tamakoshi K., Yatsuya H., Kondo T., Hori Y., Ishikawa M., Zhang H., . . . Toyoshima H. (2003). The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade infl ammatory state. International Journal of Obesity, 27, 443-449.
Tchernof A., Nolan A., Sites C. K., Ades P. A. and Poehlman, E. T. (2002). Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Woman. American Heart Association, 105, 564-569.
Visser M., Bouter L. M., McQuillan G. M., Wener M. H. and Harris, T. B. (1999). Elevated C-Reactive Protein Levels in Overweight and Obese Adults. Journal of the American Medical Association, 282(22), 2131-2135.
Mold C. H. G. and Du Clos T. W. (1999). Regulation of complement activation by C-reactive protein. US National Library of Medicine National Institutes of Health, 42(1-3), 23-30.
Nakamura M., Takahashi M., Ohno K., Koshino A., Nakashima K., Setoguchi A., . . . Tsujimoto H. (2008). C-Reactive Protein Concentration in Dogs with Various Diseases. Journal of Veterinary Medical Science., 70(2), 127-131.
Osei-Bimphong A., Meek J. H. and Lewis S. M. (2007). ESR or CRP? A comparison of their clinical utility. Hematology, 12(4), 353-357.
Paffen E. and deMaat M. P. M. (2006). C-reactive protein in atherosclerosis : A causal factor? Cardiovascular Research, 71(1), 30-39.
Peisajovich A., Marnell L., Mold C. and Du Clos T. W. (2008). C-reactive protein at the interface between innate immunity and infl ammation. Expert Review Clinical Immunology, 4(3), 379-390.
Pradhan A. D., Manson J. E., Rifai N., Buring J. E. and Ridker, P. M. (2001). C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. Journal of the American Medical Association, 286(3), 327-334.
R. O. Leal, S. Gil, N. Sepúlveda, D. McGahie, A. Duarte, M. M. R. E. Niza, & Tavares, L. (2014). Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-v therapy. Journal of Small Animal Practice, 55, 39-45.
Roman Dabrowski, Marek Szczubial, Krzysztof Kostro, Wladyslaw Wawron, Jose J. Ceron, & Tvarijonaviciute, A. (2014). Serum insulin-like growth factor-1 and C-reactive protein concentrations before and after ovariohysterectomy in bitches with pyometra. Theriogenology 83(4), 474-7.
Rutemark, C., Alicot, E., Bergman, A., Ma, M., Getahun, A., Ellmerich, S., … Heyman, B. (2011). Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proceedings of the National Academy of Sciences of the United States of America, 108 (43), E934–942.
Shida T., Kuribayashi T., Seita T., Maruo T. and Yamamoto S. (2011). Characteristics of C-reactive protein(CRP), alpha-acid Glycoprotein(AAG) and Serum Amyloid A (SAA) in Dogs and Cats with Malignant cancer. International Journal of Applied Research in Veterinary Medicine, 9(4), 376-381.
Sjöwall, C., Wetterö, J., Bengtsson, T., Askendal, A., Almroth, G., Skogh, T., & Tengvall, P. (2007). Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fl uid-phase CRP–C1q interaction. Biochemical and Biophysical Research Communications, 352(1), 251–258.
Smith, R. P., & Lipworth, B. J. (1995). C-reactive protein in simple community-acquired pneumonia. Chest, 107(4), 1028–1031.
Tamakoshi K., Yatsuya H., Kondo T., Hori Y., Ishikawa M., Zhang H., . . . Toyoshima H. (2003). The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade infl ammatory state. International Journal of Obesity, 27, 443-449.
Tchernof A., Nolan A., Sites C. K., Ades P. A. and Poehlman, E. T. (2002). Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Woman. American Heart Association, 105, 564-569.
Visser M., Bouter L. M., McQuillan G. M., Wener M. H. and Harris, T. B. (1999). Elevated C-Reactive Protein Levels in Overweight and Obese Adults. Journal of the American Medical Association, 282(22), 2131-2135.